HIGHLIGHTS
- What: The aim of the analysis was to compare the outcomes of patients undergoing or donor (MUD/MMUD) allo-HCT with graft-versus-host disease (GvHD) prophylaxis based on either ATG-T or total of patients who had undergone allo-HCT between and were included. In recent years, this approach has been extended to sibling donor allo-HCT as well . The authors performed a retrospective analysis of patients suffering from various hematological conditions who sustained matched and mismatched unrelated allo-HCT and compared the outcomes of 40 patients who received ATG-T with those of 47 patients . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.